UFL1 antisense RNA 1 (UFL1-AS1)

UFL1 antisense RNA 1 (UFL1-AS1) is annotated as an antisense non-coding RNA gene, with limited functional characterization available in publicly indexed databases or scientific literature. It is not a receptor, enzyme, transporter, or a protein-coding gene, and there is no evidence it serves as a validated or hypothesized therapeutic target. UFL1-AS1 is distinct from "UFM1-specific ligase 1" (UFL1), which is a well-studied protein-coding gene and central enzyme in the UFMylation pathway[1][2][3][4][6]. There are no known aliases, biological roles, or disease associations for UFL1-AS1, and it does not have known drug interactions or biomarker utility. Its annotation appears to be mainly genomic, as supported by NCBI Gene records[5]. Notes: - The query target "UFL1-AS1" is easily confused with the protein-coding "UFL1"—the latter *is* a widely studied E3 ligase with roles in stress response and tumorigenesis, but "UFL1-AS1" itself is an antisense transcript with insufficient supporting literature to characterize its function or target eligibility[5]. - Thus, "UFL1-AS1" is not considered a validated molecular target for drug discovery or therapeutic intervention. Summary of critical points: - UFL1-AS1 is only an antisense RNA of the UFL1 gene, not a molecular target. - No evidence exists for any direct role in disease, function, or drug interactions. - The entry is likely included due to genomic annotation practices rather than scientific or therapeutic significance[5].

None known